Secondary Logo

September/October 2018 - Volume 41 - Issue 5
pp: 151-198

Clostridium butyricum MIYAIRI 588 as Adjunctive Therapy for Treatment-Resistant Major Depressive Disorder: A Prospective Open-Label Trial

Miyaoka, Tsuyoshi; Kanayama, Misako; Wake, Rei; More

Clinical Neuropharmacology. 41(5):151-155, September/October 2018.

Tetrahydrocannabinol/Cannabidiol Oromucosal Spray in Patients With Multiple Sclerosis: A Pilot Study on the Plasma Concentration-Effect Relationship

Contin, Manuela; Mancinelli, Luca; Perrone, Alessandro; More

Clinical Neuropharmacology. 41(5):171-176, September/October 2018.

Movement Disorders After Exposure to Antipsychotic Drugs in Patients With Depressive Disorders

Rey, María Verónica; Molina, Luis; Recinos, Byron; More

Clinical Neuropharmacology. 41(5):177-180, September/October 2018.